ProShares Ultra Nasdaq Biotechnology (BIB)

Add to Watchlists
Create an Alert
100.56 +3.19  +3.28% NASDAQ Oct 20, 8:00PM BATS Real time Currency in USD
View Full Chart
BIB Price Chart

BIB Description

ProShares Ultra Nasdaq Biotechnology is a long-short equity fund managed by ProShares that tracks the NASDAQ Biotechnology TR USD index and has 306.58M USD assets under management. It has a Forecasted PE Ratio of 29.59 and a Forecasted Price to Book Value of 6.685. The fund has a net expense ratio of 0.95%, turns over its positions 26.00% per year, and is traded on the NASDAQ.

Benchmark Index: NASDAQ Biotechnology TR USD

BIB Key Info

Expense Ratio (10-1-14) 0.95%
Assets Under Management (10-17-14) 306.58M
30-Day Average Volume (10-20-14) 233884.2
Net Asset Value (10-20-14) 97.33
Discount or Premium to NAV (10-17-14) 0.04%
Turnover Ratio (5-31-14) 26.00%

BIB Asset Allocation

Type % Net % Long % Short
Cash -99.42% 29.97% 129.4%
Stock 163.8% 164.6% 0.77%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 35.62% 35.62% 0.00%
As of Sept. 30, 2014

BIB Region Exposure

Americas 95.77%
North America 95.77%
Latin America 0.00%
Greater Europe 4.17%
United Kingdom 1.88%
Europe Developed 2.29%
Europe Emerging 0.00%
Africa/Middle East 0.00%
Greater Asia 0.06%
Japan 0.00%
Australasia 0.00%
Asia Developed 0.00%
Asia Emerging 0.06%
Market Classification
% Developed Markets 99.94%
% Emerging Markets 0.06%
As of Sept. 30, 2014
Region breakdown data is calculated by using the long position holdings of the portfolio.

BIB Stock Sector Exposure

Basic Materials 0.00%
Communication Services 0.00%
Consumer Cyclical 0.00%
Consumer Defensive 0.00%
Energy 0.00%
Financial Services 0.00%
Healthcare 0.00%
Industrials 0.00%
Real Estate 0.00%
Technology 0.00%
Utilities 0.00%
As of Sept. 30, 2014

BIB Stock Market Capitalization

Giant --
Large --
Medium --
Small --
Micro --
As of Sept. 30, 2014
View More Holdings

BIB Top 10 Holdings

Name % Weight Price Chg %
Nasdaq Biotechnology Index Swap Ubs Ag 55.15% -- --
Ishares Biotech (Ibb) Swap Deutsche Bank Ag 25.99% -- --
Nasdaq Biotechnology Index Swap Credit Suisse International 19.16% -- --
Nasdaq Biotechnology Index Swap Bank Of America, Na 10.33% -- --
Amgen Inc 5.80% 137.51 +2.86%
Celgene Corp 5.74% 92.00 +4.40%
Gilead Sciences Inc 5.70% 102.21 +1.45%
Biogen Idec Inc 5.55% 311.41 +1.53%
Ishares Biotech (Ibb) Swap Morgan Stanley & Co. International Plc 5.48% -- --
Nasdaq Biotechnology Index Swap Deutsche Bank Ag 5.20% -- --
As of Sept. 30, 2014
Get Quote for
Advertisement

BIB Risk Info

Beta 1.932
30 Day Average Volatility 50.65%

BIB Fundamentals

Dividend Yield TTM (10-20-14) 0.00%
Weighted Average PE Ratio --
Weighted Average Price to Sales Ratio --
Weighted Average Price to Book Ratio --
Weighted Median ROE --
Weighted Median ROA --
Forecasted Dividend Yield 0.22%
Forecasted PE Ratio 29.59
Forecasted Price to Sales Ratio 7.222
Forecasted Price to Book Ratio 6.685
Number of Holdings 126.00
As of Sept. 30, 2014

BIB Growth Estimates

Forecasted 5 Yr Earnings Growth 15.37%
Forecasted Book Value Growth 10.37%
Forecasted Cash Flow Growth 10.96%
Forecasted Earnings Growth 30.65%
Forecasted Revenue Growth 11.95%
As of Sept. 30, 2014

BIB Performance

  Returns Total Returns
1M -4.50% -4.50%
3M 14.38% 14.38%
6M 44.03% 44.03%
1Y 58.88% 58.88%
3Y 580.6% 580.6%
5Y -- --
As of Oct. 20, 2014

BIB Flows

1M -20.86M
3M -73.61M
6M -111.02M
YTD 20.72M
1Y 51.56M
3Y 127.37M
5Y --
As of Sept. 30, 2014
Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts Professional.
Start your Free 14-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 14 Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.